Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Pariente

Showing results (211-220 of 220) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 220 results.
Studies in Health Technology and Informatics|September 12, 2009
A semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European eu-ADR projectPaul Avillach, Fleur Mougin, Michel Joubert, et al.
Drug Safety|April 13, 2025
Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of PharmacovigilanceSalvatore Crisafulli, Andrew Bate, Jeffrey Stuart Brown, et al.
Studies in Health Technology and Informatics|September 16, 2010
Design and evaluation of a semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European EU-ADR projectPaul Avillach, Michel Joubert, Frantz Thiessard, et al.
Pharmacoepidemiology and Drug Safety|September 17, 2009
Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?Gianluca Trifirò, Antoine Pariente, Preciosa M Coloma, et al.
The Lancet Regional Health. Europe|August 15, 2022
Correction to "Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study"Naïm Ouldali, Haleh Bagheri, Francesco Salvo, et al.
The Lancet Regional Health. Europe|May 4, 2022
Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance studyNaïm Ouldali, Haleh Bagheri, Francesco Salvo, et al.
Therapie|June 4, 2021
Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance CentresValérie Gras-Champel, Sophie Liabeuf, Mariette Baud, et al.
Therapie|December 5, 2024
The enhanced national pharmacovigilance system implemented for COVID-19 vaccines in France: A 2-year experience reportSamuel Crommelynck, Aurélie Grandvuillemin, Claire Ferard, et al.
Drug Safety|May 7, 2024
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and StatementMichele Fusaroli, Francesco Salvo, Bernard Begaud, et al.
Drug Safety|May 7, 2024
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and ElaborationMichele Fusaroli, Francesco Salvo, Bernard Begaud, et al.
Pageof 22

Showing results (211-220 of 220) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 220 results.
Studies in Health Technology and Informatics|September 12, 2009
A semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European eu-ADR projectPaul Avillach, Fleur Mougin, Michel Joubert, et al.
Drug Safety|April 13, 2025
Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of PharmacovigilanceSalvatore Crisafulli, Andrew Bate, Jeffrey Stuart Brown, et al.
Studies in Health Technology and Informatics|September 16, 2010
Design and evaluation of a semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European EU-ADR projectPaul Avillach, Michel Joubert, Frantz Thiessard, et al.
Pharmacoepidemiology and Drug Safety|September 17, 2009
Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?Gianluca Trifirò, Antoine Pariente, Preciosa M Coloma, et al.
The Lancet Regional Health. Europe|August 15, 2022
Correction to "Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study"Naïm Ouldali, Haleh Bagheri, Francesco Salvo, et al.
The Lancet Regional Health. Europe|May 4, 2022
Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance studyNaïm Ouldali, Haleh Bagheri, Francesco Salvo, et al.
Therapie|June 4, 2021
Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance CentresValérie Gras-Champel, Sophie Liabeuf, Mariette Baud, et al.
Therapie|December 5, 2024
The enhanced national pharmacovigilance system implemented for COVID-19 vaccines in France: A 2-year experience reportSamuel Crommelynck, Aurélie Grandvuillemin, Claire Ferard, et al.
Drug Safety|May 7, 2024
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and StatementMichele Fusaroli, Francesco Salvo, Bernard Begaud, et al.
Drug Safety|May 7, 2024
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and ElaborationMichele Fusaroli, Francesco Salvo, Bernard Begaud, et al.
Pageof 22